4 found
Order:
  1.  17
    “By only considering the end product it means that our participation has always been in vain”: Defining benefits in HIV vaccine trials in Tanzania.Godwin Pancras, Mangi Ezekiel, David Nderitu, Bege Dauda & Erasto Vitus Mbugi - 2023 - Developing World Bioethics 23 (3):220-228.
    Debates about what constitutes benefits in human research continue to be less informed due to a lack of empirical evidence from the developing world. This study aimed to explore what constitutes benefits in HIV vaccine trials in Tanzania and examine inherent ethical implications. A qualitative case study design was deployed and a total of 29 purposively selected study participants comprising of experienced researchers, institutional review board members and community advisory board members were included. Collected data were analyzed by thematic analysis (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  2.  11
    Can HIV vaccines be shared fairly? Perspectives from Tanzania.Jon F. Merz, Erasto Mbugi, David Nderitu, Mangi Ezekiel & Godwin Pancras - 2022 - BMC Medical Ethics 23 (1):1–9.
    BackgroundFor over 35 years, Africa has continued to host HIV vaccine trials geared towards overturning the HIV/aids pandemic in the continent. However, the methods of sharing the vaccines, when available remain less certain. Therefore, the study aims to explore stakeholders’ perspectives in the global South, in this case, Tanzania, on how HIV vaccines ought to be fairly shared.MethodsThe study deployed a qualitative case study design. Data were collected through in-depth interviews and focus group discussions with a total of 37 purposively (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  3.  17
    Who to engage in HIV vaccine trial benefit-sharing negotiations? An empirical proposition of a framework.Godwin Pancras, Mangi Ezekiel, Erasto Mbugi & Jon F. Merz - 2024 - BMC Medical Ethics 25 (1):1-8.
    Background A morally sound framework for benefit-sharing is crucial to minimize research exploitation for research conducted in developing countries. However, in practice, it remains uncertain which stakeholders should be involved in the decision-making process regarding benefit-sharing and what the implications might be. Therefore the study aimed to empirically propose a framework for benefit-sharing negotiations in research by taking HIV vaccine trials as a case. Methods The study was conducted in Tanzania using a case study design and qualitative approaches. Data were (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  4.  9
    Should HIV Vaccines Be Made Available at No or Subsidized Cost? A Qualitative Inquiry of HIV Vaccine Trial Stakeholders in Tanzania.Godwin Pancras, Mangi Ezekiel, Erasto Mbugi & Jon F. Merz - forthcoming - AJOB Empirical Bioethics.
    Background The world has come closer than ever to discovering a viable HIV vaccine. However, it remains less certain whether HIV vaccines should be made available to participants and communities in which trials are run no or subsidized cost. Hence the essence of this inquiry.Methodology This is a case study design using in-depth interviews (IDI) and focus group discussions (FGD) with researchers of HIV vaccine trials, institutional review board (IRB) members, HIV advocates, a policy maker, and members of community advisory (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark